Pieris Pharmaceuticals Free Cash Flow 1970-1969 | PVLA

Pieris Pharmaceuticals free cash flow from 1970 to 1969. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
Pieris Pharmaceuticals Annual Free Cash Flow
Pieris Pharmaceuticals Quarterly Free Cash Flow
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.016B $0.043B
Pieris Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's drug technology consists of Anticalin(R) to treat cancer, severe asthma, anemia and other medical conditions. Pieris Pharmaceuticals, Inc. is based in Freising-Weihenstephan, Germany.
Stock Name Country Market Cap PE Ratio
NPK (NPKI) United States $0.626B 27.85
Performant Healthcare (PHLT) United States $0.245B 0.00
FTAC Emerald Acquisition (FLDD) United States $0.158B 0.00
Swiftmerge Acquisition (ANNA) United States $0.042B 0.00
Insight Acquisition (AMOD) United States $0.023B 0.00
Hanryu Holdings (GITS) South Korea $0.017B 0.00
LQR House (YHC) United States $0.011B 0.00
ATIF Holdings (ZBAI) China $0.009B 0.00
Lion Electric (LEVGQ) Canada $0.000B 0.00